MedPath

Transdermal Lidocaine for Pain Control During Diagnostic Office Hysteroscopy

Not Applicable
Conditions
Infertility, Female
Interventions
Drug: Sham patch
Registration Number
NCT04518202
Lead Sponsor
Aswan University Hospital
Brief Summary

To compare the effectiveness of Transdermal Lidocaine for Pain Control During Diagnostic Office Hysteroscopy

Detailed Description

hysteroscopy is commonly used in the diagnosis and treatment of intrauterine lesions such as polyps, fibroids, septa, and adhesions, and in the presence of abnormal bleeding and during the removal of an intrauterine device or foreign body. Cervical ripening is made possible by the use of medication through different routes.

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
200
Inclusion Criteria
  • patients with an indication for office hysteroscopy
Exclusion Criteria
  • patient refuse to participant
  • contraindication for lidocaine patch

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
lidocaine patchlidocaine patch5% lidocaine patch applied at 6 hours before the scheduled office hysteroscopy.
Sham patchSham patchSham patch applied at 6 hours before the scheduled office hysteroscopy.
Primary Outcome Measures
NameTimeMethod
Pain intensity will be assessed by visual analogue scale10 minutes

Pain intensity will be assessed by visual analogue scale 30 minutes after the procedure. Visual analogue scale ranging from 0 to 10

Secondary Outcome Measures
NameTimeMethod
Operative time15 minutes

From the introduction of hysteroscope into the vagina till compilation of hysteroscopic examination

Trial Locations

Locations (1)

Aswan University Hospital

🇪🇬

Aswan, Egypt

© Copyright 2025. All Rights Reserved by MedPath